HIGHLIGHTS
- who: Diana Horta and colleagues from the Department of Gastroenterology and Hepatology, Hospital Universitari Mútua Terrassa, Universitat de Barcelona, Terrassa, Spain have published the article: Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice, in the Journal: Vaccines 2022, 1323 of 13/08/2022
SUMMARY
Cirrhotic patients present innate and adaptive immune dysfunction, which results in an increased risk of contracting infections. The administration of HBV and hepatitis A virus (HAV) vaccines is recommended to all patients with chronic liver disease to whom . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.